Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Frahm

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Current Infectious Disease Reports|February 28, 2007
HIV viral diversity and escape from cellular immunityNicole Frahm, Christian Brander
Expert Opinion on Biological Therapy|January 19, 2017
Current views on the potential for development of a HIV vaccineKristen W Cohen, Nicole Frahm
AIDS (London, England)|February 20, 2010
Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodiesM Patricia D'Souza, Nicole Frahm
Nature Protocols|March 14, 2009
The role of IFN-gamma Elispot assay in HIV vaccine researchHendrik Streeck, Nicole Frahm, Bruce D Walker
Current Opinion in Immunology|June 17, 2006
The challenges of host and viral diversity in HIV vaccine designChristian Brander, Nicole Frahm, Bruce D Walker
BMC Immunology|January 24, 2008
HLA class I supertypes: a revised and updated classificationJohn Sidney, Bjoern Peters, Nicole Frahm, et al.
Plos Computational Biology|October 17, 2007
A statistical framework for modeling HLA-dependent T cell response dataJennifer Listgarten, Nicole Frahm, Carl Kadie, et al.
Plos Computational Biology|July 20, 2023
Gene signature discovery and systematic validation across diverse clinical cohorts for TB prognosis and response to treatmentRoger Vargas, Liam Abbott, Daniel Bower, et al.
Nature Communications|November 3, 2019
CXCR3 enables recruitment and site-specific bystander activation of memory CD8<sup>+</sup> T cellsNicholas J Maurice, M Juliana McElrath, Erica Andersen-Nissen, et al.
Journal of Biopharmaceutical Statistics|June 12, 2014
Nonlinear Calibration Model Choice between the Four and Five-Parameter Logistic ModelsWilliam N Cumberland, Youyi Fong, Xuesong Yu, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Current Infectious Disease Reports|February 28, 2007
HIV viral diversity and escape from cellular immunityNicole Frahm, Christian Brander
Expert Opinion on Biological Therapy|January 19, 2017
Current views on the potential for development of a HIV vaccineKristen W Cohen, Nicole Frahm
AIDS (London, England)|February 20, 2010
Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodiesM Patricia D'Souza, Nicole Frahm
Nature Protocols|March 14, 2009
The role of IFN-gamma Elispot assay in HIV vaccine researchHendrik Streeck, Nicole Frahm, Bruce D Walker
Current Opinion in Immunology|June 17, 2006
The challenges of host and viral diversity in HIV vaccine designChristian Brander, Nicole Frahm, Bruce D Walker
BMC Immunology|January 24, 2008
HLA class I supertypes: a revised and updated classificationJohn Sidney, Bjoern Peters, Nicole Frahm, et al.
Plos Computational Biology|October 17, 2007
A statistical framework for modeling HLA-dependent T cell response dataJennifer Listgarten, Nicole Frahm, Carl Kadie, et al.
Plos Computational Biology|July 20, 2023
Gene signature discovery and systematic validation across diverse clinical cohorts for TB prognosis and response to treatmentRoger Vargas, Liam Abbott, Daniel Bower, et al.
Nature Communications|November 3, 2019
CXCR3 enables recruitment and site-specific bystander activation of memory CD8<sup>+</sup> T cellsNicholas J Maurice, M Juliana McElrath, Erica Andersen-Nissen, et al.
Journal of Biopharmaceutical Statistics|June 12, 2014
Nonlinear Calibration Model Choice between the Four and Five-Parameter Logistic ModelsWilliam N Cumberland, Youyi Fong, Xuesong Yu, et al.
Pageof 12